June 2020
Volume 61, Issue 7
ARVO Annual Meeting Abstract  |   June 2020
Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation
Author Affiliations & Notes
  • Qian Liu
    Henan Eye Institute,University of California San Francisco, China
  • Murtaza Saifee
    University of California San Francisco, Department of Ophthalmology, California, United States
  • Yinxi Yu
    University of Pennsylvania, Pennsylvania, United States
  • Gui-Shuang Ying
    University of Pennsylvania, Pennsylvania, United States
  • Ying Han
    University of California San Francisco, California, United States
  • Footnotes
    Commercial Relationships   Qian Liu, None; Murtaza Saifee, None; Yinxi Yu, None; Gui-Shuang Ying, None; Ying Han, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3888. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Qian Liu, Murtaza Saifee, Yinxi Yu, Gui-Shuang Ying, Ying Han; Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3888.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Purpose: To determine the change in global and regional Humphrey visual field (VF) after glaucoma drainage device (GDD) implantation in glaucomatous eyes over 3-year follow-up.

Methods : Methods: Patients undergoing placement of an Ahmed, Baerveldt, or Molteno implant from 2010-2015 at the University of California, San Francisco. Patients who underwent GDD placement with reliable pre-operative and yearly post-operative VF measurements were included in this study. Clinical parameters were compared between pre-operative and follow-up visits, including visual acuity, intraocular pressure (IOP), number of glaucoma medications, global VF metrics (mean deviation (MD), pattern standard deviation (PSD), Collaborative Initial Glaucoma Treatment Study (CIGTS) score on total deviation probability (CIGTS_TDP) and pattern deviation probability (CIGTS_PDP)), and regional metrics (regional total deviation (TD), regional pattern deviation (PD), and regional CIGTS_TDP and CIGTS_PDP). Univariate and multivariate regression analyses were performed to determine risk factors for VF worsening after GDD implantation surgery.

Results : Results: A total of 106 eyes from 95 patients were included in the study with an age (mean ± standard deviation) of 65.9±15.9 years. Sixty-seven (63.2%) eyes were pseudophakic at presentation. IOP (mean±standard deviation) was reduced from 23.1±8.5 mmHg to 12.7±3.1 mmHg at 3-year follow-up (P<0.001). Mean preoperative MD, PSD, CIGTS_TDP and CIGTS_PDP were -11.7±7.8 dB, 7.8±3.8, 12.8±6.2 and 8.2±6.0, respectively. MD, PSD and global CIGTS_PDP showed no statistically significant changes in follow-up, whereas global CIGTS_TDP showed mild progression from 10.7 to 12.8 at 3-year follow-up (p = 0.01). No regional metrics showed worsening in follow-up. Defects in the superior hemifield was more common than in inferior hemifield at baseline and follow-ups for all regional metrics. Pre-operative number of glaucoma medications was found to be associated with worsening on CIGTS_TDP.

Conclusions : Conclusion: Overall, GDD implantation surgery is effective at reducing IOP and stabilizing VF function in glaucomatous eyes over 3-years of follow-up. The superior hemifield is affected more severely compared to the other regions. The number of pre-operative glaucoma medications is associated with mild VF progression measured by CIGTS_TDP.

This is a 2020 ARVO Annual Meeting abstract.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.